Eli Lilly and Co
- Country
- 🇺🇸United States
- Ownership
- -
- Employees
- 43K
- Market Cap
- $859.4B
- Introduction
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.
A Study in Erectile Dysfunction
- First Posted Date
- 2009-02-02
- Last Posted Date
- 2010-08-24
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 372
- Registration Number
- NCT00833638
- Locations
- 🇺🇸
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Indianapolis, Indiana, United States
A Comparison of Antiplatelet Therapies in Asian Subjects With Acute Coronary Syndrome
- First Posted Date
- 2009-01-28
- Last Posted Date
- 2011-11-02
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 720
- Registration Number
- NCT00830960
- Locations
- 🇹🇭
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Chiang Mai, Thailand
Study to Treat Patients Who Have Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) With Tadalafil Daily
- First Posted Date
- 2009-01-22
- Last Posted Date
- 2010-11-17
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 325
- Registration Number
- NCT00827242
- Locations
- 🇲🇽
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Zapopan, Mexico
Early Versus Delayed Switch in Medication in Patients With Major Depressive Disorder
- Conditions
- Major Depressive Disorder
- Interventions
- First Posted Date
- 2008-12-17
- Last Posted Date
- 2011-06-21
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 840
- Registration Number
- NCT00810069
- Locations
- 🇪🇸
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph, Vigo, Spain
🇹🇷For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician, Sisli, Turkey
Study in Participants With Acute Migraines Headaches
- Conditions
- Migraine Headache
- Interventions
- First Posted Date
- 2008-12-09
- Last Posted Date
- 2020-05-19
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 120
- Registration Number
- NCT00804973
- Locations
- 🇺🇸
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Norfolk, Virginia, United States
A Study for Patients With Type 2 Diabetes Mellitus
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- Drug: LY2428757Drug: Placebo
- First Posted Date
- 2008-12-09
- Last Posted Date
- 2011-07-14
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 247
- Registration Number
- NCT00804986
- Locations
- 🇬🇧
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Liverpool, United Kingdom
A Study in the Treatment of Alcohol Dependence.
- Conditions
- Alcohol Dependence
- Interventions
- Drug: LY686017Drug: Placebo
- First Posted Date
- 2008-12-09
- Last Posted Date
- 2019-09-17
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 190
- Registration Number
- NCT00805441
- Locations
- 🇺🇸
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Seattle, Washington, United States
A Study for the Treatment of Alcohol Dependence
- Conditions
- Alcohol Dependence
- Interventions
- Drug: LY2196044Drug: placebo
- First Posted Date
- 2008-12-09
- Last Posted Date
- 2019-09-24
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 375
- Registration Number
- NCT00804570
- Locations
- 🇺🇸
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Seattle, Washington, United States
Duloxetine for the Treatment of Generalized Anxiety Disorder
- First Posted Date
- 2008-12-05
- Last Posted Date
- 2010-12-17
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 210
- Registration Number
- NCT00803361
- Locations
- 🇨🇳
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Xi'An, China
Follow-up Data of Patients Treated With XIGRIS® in France
- Conditions
- Sepsis
- First Posted Date
- 2008-12-05
- Last Posted Date
- 2010-02-02
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 1004
- Registration Number
- NCT00803231
- Locations
- 🇫🇷
For additional information regarding investigative sites for this study, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Suresnes, France